Finley John David

Average Profitability
<0.0001%
Insider Buys Quantity
10
Insider Buys Sum
$76,502.70
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Finley John David

According to the SEC Form 4 filings, Finley John David, being in a position of

  1. CEO, CFO, Director at Palisade Bio, Inc.,
    оver the last 12 months, has bought 21000 shares for $15,092, and sold 0 shares,
    over all time since 2021-08-27, has bought 97331 share for $76,503, and sold 0 shares.

The largest purchase of all time was on 2021-08-27 and amounted to 10000 shares of Palisade Bio, Inc. for $26,468.

Biography of Finley John David

No biography is available at this moment.

2024-05-24PurchasePalisade Bio, Inc.
PALI
CEO, CFO, Director
1,000
0.0994%
$4.81$4,810-23.42%
2024-02-06PurchasePalisade Bio, Inc.
PALI
CEO, CFO, Director
10,000
0.0819%
$0.47$4,692-28.34%
2024-01-31PurchasePalisade Bio, Inc.
PALI
CEO, CFO, Director
10,000
0.0976%
$0.56$5,590-45.16%
2023-09-27PurchasePalisade Bio, Inc.
PALI
CEO, CFO, Director
15,000
0.1655%
$0.54$8,088-20.7%
2023-09-13PurchasePalisade Bio, Inc.
PALI
CEO, CFO, Director
15,000
0.2077%
$0.66$9,825-32.1%
2022-09-01PurchasePalisade Bio, Inc.
PALI
Chief Financial Officer
19,481.24
0.0402%
$0.14$2,799-69.79%
2022-08-23PurchasePalisade Bio, Inc.
PALI
Chief Financial Officer
7,350
0.0144%
$0.16$1,176-73.51%
2022-03-24PurchasePalisade Bio, Inc.
PALI
Chief Financial Officer
7,500
0.045%
$1.09$8,174-89.78%
2021-09-21PurchasePalisade Bio, Inc.
PALI
Chief Financial Officer
2,000
0.0164%
$2.44$4,880-62%
2021-08-27PurchasePalisade Bio, Inc.
PALI
Chief Financial Officer
10,000
0.0865%
$2.65$26,468-60.08%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.